Prix KDA Group Inc (KDAGF)

KDA Group, Inc. engages in the provision of solutions and services to the pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The firm operates through Pharmaceutical Technology segment. The company is focused on developing technological products across four different platforms: KRx, Medherize, CareMedic and Adherize+. The KRx is an advanced electronic prescription platform that simplifies and secures the prescribing process for medical clinics. Medherize is a specialized module of Adherize+, which focuses on patients undergoing complex therapies, such as oral oncology treatments. CareMedic is its integrated digital health record and care coordination platform. The company centralizes patient information, including medical history, lab results, allergies, and medication schedules and enables secure communication among providers and with patients. Adherize+ is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions.